Inmune Bio (INMB) Asset Utilization Ratio (2021 - 2025)
Historic Asset Utilization Ratio for Inmune Bio (INMB) over the last 5 years, with Q3 2025 value amounting to 0.0.
- Inmune Bio's Asset Utilization Ratio rose 7634.61% to 0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0, marking a year-over-year increase of 7634.61%. This contributed to the annual value of 0.0 for FY2024, which is 8701.74% down from last year.
- Inmune Bio's Asset Utilization Ratio amounted to 0.0 in Q3 2025, which was up 7634.61% from 0.0 recorded in Q2 2025.
- In the past 5 years, Inmune Bio's Asset Utilization Ratio ranged from a high of 0.01 in Q3 2022 and a low of 0.0 during Q2 2021
- In the last 5 years, Inmune Bio's Asset Utilization Ratio had a median value of 0.0 in 2021 and averaged 0.0.
- In the last 5 years, Inmune Bio's Asset Utilization Ratio soared by 608410.32% in 2022 and then plummeted by 8829.21% in 2024.
- Inmune Bio's Asset Utilization Ratio (Quarter) stood at 0.0 in 2021, then soared by 159.06% to 0.0 in 2022, then plummeted by 42.67% to 0.0 in 2023, then crashed by 88.29% to 0.0 in 2024, then skyrocketed by 364.23% to 0.0 in 2025.
- Its Asset Utilization Ratio was 0.0 in Q3 2025, compared to 0.0 in Q2 2025 and 0.0 in Q1 2025.